Quincy Bioscience is a biotechnology company based in Madison, Wisconsin, that focuses on the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges associated with aging. Quincy Bioscience is set apart by its cutting-edge applications of apoaequorin which is breaking new ground with apoaequorin, originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility. The discovery and development of apoaequorin in 1962 earned the scientists responsible great acclaim. Quincy Bioscience is building on this work through its novel use of apoaequorin. Apoaequorin achieved self-affirmed GRAS status (generally recognized as safe) after an independent panel of expert scientists concluded that apoaequorin is safe for use in food products. Prevagen® is the company’s flagship consumer brand containing apoaequorin. A landmark double-blind and placebo-controlled trial demonstrated the ability to improve aspects of cognitive function in participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. Prevagen is now the best-selling brain health supplement in chain pharmacies across America according to Nielsen data. Quincy Bioscience offers a competitive compensation package including: Health Insurance effective on first day of employment Dental, Vision, Life, Short-Term and Long-Term Disability Insurance Flex Spending 401(k) Paid Vacation